Studies of rat and human retinas predict a role for the polyol pathway in human diabetic retinopathy

Diabetes

Volumn 53, Issue 9, 2004, Pages 2404-2411

  Dagher, Zeina ^a   Park, Yong Seek ^a   Asnaghi, Veronica ^a   Hoehn, Todd ^a   Gerhardinger, Chiara ^a   Lorenzi, Mara ^a  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE REDUCTASE; ALDOSE REDUCTASE INHIBITOR; COMPLEMENT INHIBITOR; GALACTOSE; GLUCOSE; POLYOL; SORBITOL;

ACELLULAR CAPILLARY; ADOLESCENT; ADULT; AGED; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CAPILLARY; CELL LEVEL; CELL METABOLISM; CELL STRESS; CELL TYPE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; DIABETIC RETINOPATHY; ENDOTHELIUM CELL; ENZYME ACTIVITY; FEMALE; GALACTOSE INDUCED RETINOPATHY; GLUCOSE CELL LEVEL; GLUCOSE METABOLISM; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREACTIVITY; MALE; METABOLIC INHIBITION; NONHUMAN; ORGAN CULTURE; PATHOGENESIS; PERICYTE; POLYOL PATHWAY; PRIORITY JOURNAL; RAT; RETINA BLOOD VESSEL; RETINOPATHY; STREPTOZOCIN DIABETES; STRESS; VASCULAR DISEASE;

AGED; ALDEHYDE REDUCTASE; ANIMALS; APOPTOSIS; CAPILLARIES; DIABETIC RETINOPATHY; ENZYME INHIBITORS; FEMALE; GLUCOSE; HUMANS; IMIDAZOLES; IMIDAZOLIDINES; MALE; MIDDLE AGED; PERICYTES; POLYMERS; RATS; RATS, SPRAGUE-DAWLEY; RETINAL VESSELS; SORBITOL;

EID: 4344658774     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.53.9.2404     Document Type: Article

References (49)

1. Lorenzi M, Gerhardinger C: Early cellular and molecular changes induced by diabetes in the retina. Diabetologia 44:791-804, 2001
2. Kohner EM: Diabetic retinopathy. Br Med Bull 45:148-173, 1989
3. Gabbay KH: The sorbitol pathway and the complications of diabetes. N Engl J Med 288:831-836, 1973
4. Oates PJ: The polyol pathway and diabetic peripheral neuropathy. In International Review of Neurobiology: The Neurobiology of Diabetic Neuropathy. Vol. 50, Tomlinson DR, Ed. London, Academic Press, 2002, p. 325-392
5. Obrosova IG, Fathallah L, Lang HJ: Interaction between osmotic and oxidative stress in diabetic precataractous lens: studies with a sorbitol dehydrogenase inhibitor. Biochem Pharmacol 58:1945-1954, 1999
6. Williamson JR, Chang K, Frangos M, Hasan KS, Ido Y, Kawamura T, Nyengaard JR, Van Den Enden M, Kilo C, Tilton RG: Hyperglycemic pseudohypoxia and diabetic complications. Diabetes 42:801-813, 1993
7. Demaine AG, Cross DF: Genetics of aldose reductase and susceptibility to diabetic retinopathy. Appl Genomics Proteomics 1:1-13, 2002
8. Ho HTB, Chung SK, Law JWS, Ko BCB, Tam SCF, Brooks HL, Knepper MA, Chung SSM: Aldose reductase-deficient mice develop nephrogenic diabetes insipidus. Mol Cell Biol 20:5840-5846, 2000
9. Kador PF, Akagi Y, Takahashi Y, Ikebe H, Wyman M, Kinoshita JH: Prevention of retinal vessel changes associated with diabetic retinopathy in galactose-fed dogs by aldose reductase inhibitors. Arch Ophthalmol 108:1301-1309, 1990
10. Engerman RL, Kern TS: Aldose reductase inhibition fails to prevent retinopathy in diabetic and galactosemic dogs. Diabetes 42:820-825, 1993
11. Sorbinil Retinopathy Trial Research Group: A randomized trial of sorbinil, an aldose reductase inhibitor, in diabetic retinopathy. Arch Ophthalmol 108:1234-1244, 1990
12. Asnaghi V, Gerhardinger C, Hoehn T, Adeboje A, Lorenzi M: A role for the polyol pathway in the early neuroretinal apoptosis and glial changes induced by diabetes in the rat. Diabetes 52:506-511, 2003
13. Ludvigson MA, Sorenson RI: Immunohistochemical localization of aldose reductase. II. Rat eye and kidney. Diabetes 29:450-459, 1980
14. Chakrabarti S, Sima AAF, Nakajima T, Yagihashi S, Greene DA: Aldose reductase in the BB rat: isolation, immunological identification and localization in the retina and peripheral nerve. Diabetologia 30:244-251, 1987
15. Kern TS, Engerman RL: Distribution of aldose reductase in ocular tissues. Exp Eye Res 33:175-182, 1981
16. Akagi Y, Yajima Y, Kador PF, Kuwabara T, Kinoshita JH: Localization of aldose reductase in the human eye. Diabetes 33:562-566, 1984
17. Dyer MA, Cepko CL: Control of Müller glial cell proliferation and activation following retinal injury. Nat Neurosci 3:873-880, 2000
18. Akagi Y, Kador PF, Kuwabara T, Kinoshita JH: Aldose reductase localization in human retinal mural cells. Invest Ophthalmol Vis Sci 24:1516-1519, 1983
19. Zhang J, Gerhardinger C, Lorenzi M: Early complement activation and decreased levels of glycosylphosphatidylinositol-anchored complement inhibitors in human and experimental diabetic retinopathy. Diabetes 51:3499-3504, 2002
20. Mizutani M, Kern TS, Lorenzi M: Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy. J Clin Invest 97:2883-2890, 1996
21. Cogan DG, Toussaint D, Kuwabara T: Retinal vascular patterns. IV. Diabetic retinopathy. Arch Ophthalmol 613:366-378, 1961
22. Kohner EM, Henkind P: Correlation of fluorescein angiogram and retinal digest in diabetic retinopathy. Am J Ophthalmol 69:403-414, 1970
23. Kern TS, Engerman RL: Comparison of retinal lesions in alloxan-diabetic rats and galactose-fed rats. Curr Eye Res 13:863-867, 1994
24. Boeri B, Cagliero E, Podestá F, Lorenzi M: Vascular wall von Willebrand factor in human diabetic retinopathy. Invest Ophthalmol Vis Sci 35:600-607, 1994
25. Podestá F, Romeo G, Liu W-H, Krajewski S, Reed JC, Gerhardinger C, Lorenzi M: Bax is increased in the retina of diabetic subjects and is associated with pericyte apoptosis in vivo and in vitro. Am J Pathol 156:1025-1032, 2000
26. Su X, Sorenson CM, Sheibani N: Isolation and characterization of murine retinal endothelial cells. Molec Vision 9:171-178, 2003
27. Gerhardinger C, McClure KD, Romeo G, Podestá F, Lorenzi M: IGF-I mRNA and signaling in the diabetic retina. Diabetes 50:175-183, 2001
28. Spiller OB, Hanna SM, Morgan BP: Tissue distribution of the rat analogue of decay-accelerating factor. Immunology 97:374-384, 1999
29. + -ATPase activity. Am J Physiol Cell Physiol 282:C560-C566, 2002
30. Malone JI, Knox G, Benford S, Tedesco TA: Red cell sorbitol: an indicator of diabetic control. Diabetes 29:861-864, 1980
31. Sharma NK, Gardiner TA, Archer DB: A morphologic and autoradiographic study of cell death and regeneration in the retinal microvasculature of normal and diabetic rats. Am J Ophthalmol 100:51-60, 1985
32. Newman PJ: The biology of PECAM-1. J Clin Invest 99:3-8, 1997
33. Das B, Srivastava SK: Activation of aldose reductase from human tissues. Diabetes 34:1145-1151, 1985
34. Tilton RG, Chang K, Pugliese G, Eades DM, Province MA, Sherman WR, Kilo C, Williamson JR: Prevention of hemodynamic and vascular albumin filtration changes in diabetic rats by aldose reductase inhibitors. Diabetes 37:1258-1270, 1989
35. Amano S, Yamagishi S, Kato N, Inagaki Y, Okamoto T, Makino M, Taniko K, Hirooka H, Jomori T, Takeuchi M: Sorbitol dehydrogenase overexpression potentiates glucose toxicity to cultured retinal pericytes. Biochem Biophys Res Commun 299:183-188, 2002
36. Kowluru RA, Tang J, Kern TS: Abnormalities of retinal metabolism in diabetes and experimental galactosemia. VII. Effect of long-term administration of antioxidants on the development of retinopathy. Diabetes 50:1938-1942, 2001
37. Hammes HP, Bartmann A, Engel L, Wülfroth P: Antioxidant treatment of experimental diabetic retinopathy in rats with nicanartine. Diabetologia 40:629-634, 1997
38. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes H-P, Giardino I, Brownlee M: Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404:787-790, 2000
39. Baynes JW, Thorpe SR: Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 48:1-9, 1999
40. Koya D, King GL: Protein kinase C activation and the development of diabetic complications. Diabetes 47:859-866, 1998
41. Rittner HL, Hafner V, Klimiuk PA, Szweda LI, Goronzy JJ, Weyand CM: Aldose reductase functions as a detoxification system for lipid peroxidation products in vasculitis. J Clin Invest 103:1007-1013, 1999
42. Obrosova IG, Minchenko AG, Vasupuram R, White L, Abatan OI, Kumagai AK, Frank RN, Stevens MJ: Aldose reductase inhibitor fidarestat prevents retinal oxidative stress and vascular endothelial growth factor overexpression in streptozotocin-diabetic rats. Diabetes 52:864-871, 2003
43. Sato S, Kador PF: Human kidney aldose and aldehyde reductases. J Diabetes Complications 7:179-187, 1993
44. Ramasamy R, Oates PJ: Aldose reductase and vascular stress. In Diabetes and Cardiovascular Disease. Marso SP, Stern DM, Eds. Philadelphia, Lippincott, Williams & Wilkins, 2004, p. 55-74
45. Romeo G, Liu W-H, Asnaghi V, Kern TS, Lorenzi M: Activation of nuclear factor-κB induced by diabetes and high glucose regulates a proapoptotic program in retinal pericytes. Diabetes 51:2241-2248, 2002
46. Genuth S: Exogenous insulin administration and cardiovascular risk in non-insulin-dependent and insulin-dependent diabetes mellitus. Ann Intern Med 124:104-109, 1996
47. Stratton IM, Adler AI, Neil HAW, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR, UK Prospective Diabetes Study Group: Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. Br Med J 321:405-412, 2000
48. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group: Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus N Engl J Med 348:2294-2303, 2000
49. Mylari BL, Armento SJ, Beebe DA, Conn EL, Coutcher JB, Dina MS, O'Gorman MT, Linhares MC, Martin WH, Oates PJ, Tess DA, Withbroe GJ, Zembrowski WJ: A highly selective, non-hydantoin, non-carboxylic acid inhibitor of aldose reductase with potent oral activity in diabetic rat models: 6-(5-chloro-3- methylbenzofuran-2-sulfonyl)-2-H-pyridazin-3-one. J Med Chem 46:2283-2286, 2003